相关实验视频
Updated: Jul 26, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
西利马林和管理非酒精性脂肪肝炎的肝功能:一个病例报告
Ahmed Hashem1,2
1Endemic Medicine Department, Cairo University, Giza, Egypt.
来自乳的西利玛林在治疗非酒精性脂肪肝炎 (NASH) 中表现有前途. 这项研究发现,在改善NASH患者肝功能方面,西利马林适度有效且安全.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 非酒精性脂肪性肝病 (NAFLD) 和其渐进的形式,非酒精性脂肪性肝炎 (NASH),是慢性肝病的主要原因.
- 目前,对于NAFLD或NASH,没有FDA批准的药理疗法.
- 乳提取物西利马林 (Silymarin) 在治疗肝脏疾病方面有着悠久的历史.
更多相关视频
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
04:14Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
Published on: April 16, 2019
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Myocarditis IV: Nursing Management
Atherosclerosis III: Management
Chronic Pancreatitis II: Collaborative Care
Assessment:
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...